FDAnews Device Daily Bulletin

BIOHEART, INC AND TRICARDIA, LLC SIGN PATENT LICENSING AGREEMENT

May 4, 2006
A A

Bioheart, Inc., a leader in developing cell therapies for heart repair, announced today the signing of a patent licensing agreement with Tricardia, LLC of Eden Prairie, Minnesota for patents covering an improved injection needle. The needle will be attached to Bioheart's SR-200 MyoCath needle injection catheter system, which is capable of delivering biological solutions to the heart.
PR Newswire